Skip to content

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03072927
Enrollment
8000
Registered
2017-03-07
Start date
2017-03-10
Completion date
2026-12-01
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Keywords

Lumbar Spinal Stenosis, Interspinous process decompression, MILD, Medicare, Medicare Advantage

Brief summary

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study will start with patients treated with a study procedure having an index date on or after January 1, 2017, and enrollment will continue until stopped by the sponsor.

Detailed description

In this study the treatment group will include all patients receiving MILD, and the control group will include all patients receiving IPD for the treatment of LSS during the enrollment period. Reoperation and harms data will be studied for the MILD and IPD procedures for a 24-month follow-up period after the index procedure using Medicare claims data. This study is exempt from IRB oversight (Department of Health and Human Services regulations 45 CFR 46) and does not require prior enrollment nor patient consent. The inclusion of the study's NCT number on MILD Medicare claims is required and results in enrollment.

Interventions

DEVICEMILD

MILD is performed under fluoroscopic image guidance through an ipsilateral interlaminar dorsal approach to the spine. Partial decompression is performed through the removal of tissue and bone at the symptomatic level confirmed with correlated MRI and clinical findings.

DEVICEInterspinous Process Decompression

Interspinous Process Decompression

Sponsors

Stryker Instruments
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medicare beneficiaries receiving MILD or interspinous process decompression * Diagnosis of LSS with NC

Exclusion criteria

* Patients that have received a laminectomy, laminotomy, fusion, interspinous process decompression, or MILD in the lumbar region during the 12 months prior to the index date

Design outcomes

Primary

MeasureTime frameDescription
Rate of participants with harms associated with the index procedure24 monthsRate of participants with harms associated with the index procedure including, but not limited to, revisions, displacement, mechanical complications, and death. Complications will be counted if they are recorded during the index hospitalization, or any rehospitalization within 30 days of discharge.
Rate of surgical, minimally invasive intervention.24 monthsMeasure the rate of Medicare beneficiary surgical and minimally invasive intervention for LSS with NC post index procedure.

Countries

United States

Contacts

CONTACTAngie Lee
angie.lee@stryker.com877-958-6227
CONTACTStephanie Guyon
stephanie.guyon@stryker.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026